BioCentury | Jan 28, 2016
Distillery Therapeutics

Therapeutics: An undetermined target

Dermatology INDICATION: Wounds Rat studies suggest a gel-based formulation of a Cecropia pachystachya extract could help treat wounds. In rats with surgical wounds, topical application of the gel increased skin regrowth and uniformity of healed...
BioCentury | Oct 14, 2013
Company News

Neuraltus management update

...Endocrine/Metabolic Hired: Richard Casey as president, CEO and a director, formerly chairman and CEO of Scios Inc....
BioCentury | Apr 15, 2013
Company News

Scios board of directors update

Scios Inc. (SCIO), Mountain View, Calif. Business: Cardiovascular, Biomaterial/Skin/Wound Appointed: Charles Sanders, formerly chairman and CEO of Glaxo Inc. WIR Staff Cardiovascular Dermatology...
BioCentury | Apr 15, 2013
Company News

Ontogeny management update

...as VP of business development; formerly executive director of business development and market planning at Scios Inc....
BioCentury | Apr 15, 2013
Company News

Scios, DuPont Merck Pharmaceutical Co. deal

...stock will be determined at closing in March 1998. SCIO has 37.9 million shares outstanding. Scios Inc....
BioCentury | Aug 20, 2012
Company News

Myrexis autoimmune, cancer news

...after nearly 35 years in the biopharma industry. He served as president and CEO of Scios Inc....
BioCentury | Aug 16, 2012
Company News

Veteran biotech exec Brewer passes away

...after nearly 35 years in the biopharma industry. He served as president and CEO of Scios Inc....
BioCentury | May 21, 2012
Company News

Myrexis management update

...Business: Cancer, Infectious Hired: Richard Brewer as president, CEO and a director, formerly CEO of Scios Inc....
BioCentury | Nov 22, 2010
Clinical News

Natrecor nesiritide: Phase III data

...JNJ's Scios Inc. subsidiary reported data from the double-blind, international Phase III ASCEND-HF trial in 7,141 patients...
BioCentury | Jul 26, 2010
Company News

Nile Therapeutics board of directors update

...as executive chairman, currently chairman of Arca biopharma Inc. and previously president and CEO of Scios Inc....
Items per page:
1 - 10 of 338
BioCentury | Jan 28, 2016
Distillery Therapeutics

Therapeutics: An undetermined target

Dermatology INDICATION: Wounds Rat studies suggest a gel-based formulation of a Cecropia pachystachya extract could help treat wounds. In rats with surgical wounds, topical application of the gel increased skin regrowth and uniformity of healed...
BioCentury | Oct 14, 2013
Company News

Neuraltus management update

...Endocrine/Metabolic Hired: Richard Casey as president, CEO and a director, formerly chairman and CEO of Scios Inc....
BioCentury | Apr 15, 2013
Company News

Scios board of directors update

Scios Inc. (SCIO), Mountain View, Calif. Business: Cardiovascular, Biomaterial/Skin/Wound Appointed: Charles Sanders, formerly chairman and CEO of Glaxo Inc. WIR Staff Cardiovascular Dermatology...
BioCentury | Apr 15, 2013
Company News

Ontogeny management update

...as VP of business development; formerly executive director of business development and market planning at Scios Inc....
BioCentury | Apr 15, 2013
Company News

Scios, DuPont Merck Pharmaceutical Co. deal

...stock will be determined at closing in March 1998. SCIO has 37.9 million shares outstanding. Scios Inc....
BioCentury | Aug 20, 2012
Company News

Myrexis autoimmune, cancer news

...after nearly 35 years in the biopharma industry. He served as president and CEO of Scios Inc....
BioCentury | Aug 16, 2012
Company News

Veteran biotech exec Brewer passes away

...after nearly 35 years in the biopharma industry. He served as president and CEO of Scios Inc....
BioCentury | May 21, 2012
Company News

Myrexis management update

...Business: Cancer, Infectious Hired: Richard Brewer as president, CEO and a director, formerly CEO of Scios Inc....
BioCentury | Nov 22, 2010
Clinical News

Natrecor nesiritide: Phase III data

...JNJ's Scios Inc. subsidiary reported data from the double-blind, international Phase III ASCEND-HF trial in 7,141 patients...
BioCentury | Jul 26, 2010
Company News

Nile Therapeutics board of directors update

...as executive chairman, currently chairman of Arca biopharma Inc. and previously president and CEO of Scios Inc....
Items per page:
1 - 10 of 338